Moderna slips 5% to about $245 after 13% jump to 52-week high, results due Friday
TIKR · · AI-summarised by FinFlash
Moderna gave back about 5% to near $245 on Thursday after surging 13% on Wednesday to a 52-week closing high of $258.38. The rally followed early myeloma data showing four confirmed responses among 11 evaluable patients and a WHO panel's backing for its Ebola candidate. Third-quarter results arrive before Friday's open, with revenue seen implied near $860 million against about At roughly 51 times forward sales against a five-year average of 7.9, the stock leaves little room for a miss. Friday's guidance and cash burn are the focus. Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.So What?
Understand the context